NANO-CNS
Live / Registered — Registered (as of 04 Nov 2025)
What this means for you
Registered since 04 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98162138
- Registration number
- 8014586
- Mark type
- Stylized text
- Filed
- 01 Sept 2023
- Published for opposition
- 28 May 2024
- Registered
- 04 Nov 2025
- Attorney of record
- Barry F. Soalt
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and molecular drugs
- Class 042 — Scientific and technological services: Research and formulation development in the pharmaceuticals and molecular drugs fields; Pharmaceutical drug development services; pharmaceutical products development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research in the field of generation of nano drug particles used to enhance the bioavailability of otherwise poorly soluble drugs; Scientific study and research in the fields of drug delivery and development of pharmaceuticals comprised of nano drug particles; Testing of pharmaceuticals
Owner
- Nano PharmaSolutions, Inc., San Diego, CA, US
- Nano PharmaSolutions, Inc., San Diego, CA, US
- Nano PharmaSolutions, Inc., San Diego, CA, US
Prosecution history
- 04 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2025 — USE AMENDMENT FILED
- 15 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2025 — SOU EXTENSION 1 GRANTED
- 16 Jan 2025 — SOU EXTENSION 1 FILED
- 16 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION